Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Review (2021)

Authors

Francisco Alves Universidade de Coimbra
Inês F. Antunes University Medical Center Groningen
Emiliano Cazzola Sacro Cuore Hospital, Verona
Frederik Cleeren Katholieke Universiteit Leuven
Bart Cornelissen University Medical Center Groningen
A.G. Denkova RST/Applied Radiation & Isotopes - AS
Jonathan Engle University of Wisconsin-Madison
Alain Faivre-Chauvet ENS-PSL Research University & CNRS
Y. Seimbille Erasmus MC
undefined More Authors More Authors External organisation
Research Group
RST/Applied Radiation & Isotopes (AS) (TU Delft)
Copyright: © 2021 Francisco Alves, Inês F. Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, A.G. Denkova, Jonathan Engle, Alain Faivre-Chauvet, Y. Seimbille, More Authors
DOI: https://doi.org/10.1186/s41181-021-00146-9
More Info
expand_more

Published Date

2021

Language

English

Faculty

Applied Sciences

Department

RST/Radiation, Science and Technology

Research Group

RST/Applied Radiation & Isotopes

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.